KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Return on Equity: 2011-2024

Historic Return on Equity for Emergent BioSolutions (EBS) over the last 14 years, with Dec 2024 value amounting to -0.34%.

  • Emergent BioSolutions' Return on Equity rose 60.00% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 60.00%. This contributed to the annual value of -0.34% for FY2024, which is 41.00% up from last year.
  • Per Emergent BioSolutions' latest filing, its Return on Equity stood at -0.34% for FY2024, which was up 54.90% from -0.75% recorded in FY2023.
  • Emergent BioSolutions' Return on Equity's 5-year high stood at 0.24% during FY2020, with a 5-year trough of -0.75% in FY2023.
  • Over the past 3 years, Emergent BioSolutions' median Return on Equity value was -0.34% (recorded in 2024), while the average stood at -0.41%.
  • Per our database at Business Quant, Emergent BioSolutions' Return on Equity tumbled by 61bps in 2023 and then spiked by 41bps in 2024.
  • Emergent BioSolutions' Return on Equity (Yearly) stood at 0.24% in 2020, then fell by 10bps to 0.14% in 2021, then declined by 28bps to -0.14% in 2022, then crashed by 61bps to -0.75% in 2023, then skyrocketed by 41bps to -0.34% in 2024.